论文部分内容阅读
作者用放射性免疫分析法测定了70例肝硬化患者和30例正常人血浆TXB_2和6-K-PGF1χ含量。其中将肝硬化患者随机分成两组,一组30例为综合治疗组(对照组),另一组40例为综合治疗加前列腺素E_1治疗组(实验组)。两组治疗前以上指标经t检验差异无显著性(P<0.05),两组明显高于正常组(P<0.001)。两组均按Child分级,治疗前肝硬化
The authors used radioimmunoassay to determine the plasma levels of TXB_2 and 6-K-PGF1χ in 70 patients with cirrhosis and 30 normal controls. Patients with cirrhosis were randomly divided into two groups. One group of 30 patients were treated with combination therapy (control group), and the other group of 40 patients were treated with prostaglandin E_1 treatment (experimental group). There was no significant difference in the above indexes between the two groups by t test (P <0.05), the two groups were significantly higher than the normal group (P <0.001). Child classification by two groups, before treatment of cirrhosis